GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Beneish M-Score

Integer Holdings (Integer Holdings) Beneish M-Score : -2.60 (As of Apr. 30, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.6 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Integer Holdings's Beneish M-Score or its related term are showing as below:

ITGR' s Beneish M-Score Range Over the Past 10 Years
Min: -2.79   Med: -2.48   Max: -1.73
Current: -2.6

During the past 13 years, the highest Beneish M-Score of Integer Holdings was -1.73. The lowest was -2.79. And the median was -2.48.


Integer Holdings Beneish M-Score Historical Data

The historical data trend for Integer Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Beneish M-Score Chart

Integer Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.37 -2.67 -2.40 -2.38 -2.50

Integer Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 -2.48 -2.52 -2.50 -2.60

Competitive Comparison of Integer Holdings's Beneish M-Score

For the Medical Devices subindustry, Integer Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Beneish M-Score falls into.



Integer Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Integer Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8775+0.528 * 0.9807+0.404 * 0.9577+0.892 * 1.1307+0.115 * 1.1836
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9808+4.679 * -0.025364-0.327 * 1.0222
=-2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $331 Mil.
Revenue was 414.805 + 413.151 + 404.693 + 400.044 = $1,633 Mil.
Gross Profit was 109.84 + 110.256 + 105.556 + 105.804 = $431 Mil.
Total Current Assets was $669 Mil.
Total Assets was $3,116 Mil.
Property, Plant and Equipment(Net PPE) was $545 Mil.
Depreciation, Depletion and Amortization(DDA) was $101 Mil.
Selling, General, & Admin. Expense(SGA) was $181 Mil.
Total Current Liabilities was $201 Mil.
Long-Term Debt & Capital Lease Obligation was $1,226 Mil.
Net Income was 20.508 + 26.357 + 27.257 + 23.971 = $98 Mil.
Non Operating Income was -7.634 + -5.942 + -4.843 + -1.717 = $-20 Mil.
Cash Flow from Operations was 23.239 + 55.587 + 62.293 + 56.145 = $197 Mil.
Total Receivables was $333 Mil.
Revenue was 378.785 + 372.423 + 342.68 + 350.081 = $1,444 Mil.
Gross Profit was 96.673 + 97.916 + 86.718 + 92.897 = $374 Mil.
Total Current Assets was $629 Mil.
Total Assets was $2,874 Mil.
Property, Plant and Equipment(Net PPE) was $412 Mil.
Depreciation, Depletion and Amortization(DDA) was $94 Mil.
Selling, General, & Admin. Expense(SGA) was $163 Mil.
Total Current Liabilities was $225 Mil.
Long-Term Debt & Capital Lease Obligation was $1,062 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(330.875 / 1632.693) / (333.498 / 1443.969)
=0.202656 / 0.230959
=0.8775

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(374.204 / 1443.969) / (431.456 / 1632.693)
=0.25915 / 0.26426
=0.9807

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (668.573 + 544.585) / 3116.009) / (1 - (628.989 + 412.177) / 2873.55)
=0.610669 / 0.637673
=0.9577

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1632.693 / 1443.969
=1.1307

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(93.575 / (93.575 + 412.177)) / (100.9 / (100.9 + 544.585))
=0.185022 / 0.156317
=1.1836

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(180.662 / 1632.693) / (162.904 / 1443.969)
=0.110653 / 0.112817
=0.9808

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1225.946 + 201.429) / 3116.009) / ((1062.253 + 225.475) / 2873.55)
=0.458078 / 0.448131
=1.0222

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(98.093 - -20.136 - 197.264) / 3116.009
=-0.025364

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Integer Holdings has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.


Integer Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings (Integer Holdings) Business Description

Traded in Other Exchanges
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Executives
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy officer: SVP, Quality & Regulatory Affa 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan officer: EVP, Quality & Regulatory Affa 10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford director 2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz officer: SVP Strategy,Corp Dev., IR 10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum director 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024